Cutting-edge Spatial Omics Platform Rebus Biosystems launched the Rebus Esper spatial omics platform, offering subcellular resolution of biological molecules in tissue sections. This innovative technology presents a unique selling point for researchers looking to advance their spatial omics research.
Collaboration with Rosalind, Inc. The partnership between Rebus Biosystems and Rosalind, Inc. to co-develop new spatial omics software opens up collaboration opportunities. Sales development representatives can leverage this collaboration to introduce comprehensive solutions to potential clients in the biotechnology research field.
Key Personnel Additions With strategic hires like Amanda Smith as Vice President of Human Resources and Eric Williams as Chief Financial Officer, Rebus Biosystems is strengthening its leadership team. Highlighting these experienced professionals in sales pitches can build credibility and trust with potential partners and clients.
Publication in Science The publication of a study in Science showcasing the capabilities of Rebus Biosystems' Rebus Esper platform demonstrates the company's credibility in the scientific community. Sales representatives can leverage this achievement to position the company as a trusted partner for cutting-edge spatial omics solutions.
Strategic Talent Acquisition Rebus Biosystems' recent hires of Viet Truong as Senior VP of Product Development and Ramesh Ramakrishnan as Senior VP of Product Development signal a focus on innovation. Sales professionals can align messaging with these strategic talent acquisitions to showcase the company's commitment to advancing spatial omics technologies.
5K
$1B
234K$1B
102$10M$50M
70$10M
64K$1B
154K$1BRebus Biosystems uses 8 technology products and services including Linkedin Insight Tag, Google Font API, Google Cloud, and more. Explore Rebus Biosystems's tech stack below.
| Rebus Biosystems Email Formats | Percentage |
| FLast@rebusbio.com | 48% |
| Last@rebusbio.com | 2% |
| FLast@rebusbio.com | 48% |
| Last@rebusbio.com | 2% |
Biotechnology ResearchCalifornia, United States11-50 Employees
At Rebus Biosystems, our vision is spatial omics without compromise. Get subcellular resolution of biological molecules directly in and across large tissue sections. Customizable assays allow you to focus on the targets that matter most to your research. Available as a fully automated, integrated instrument for your lab in early 2021. Get access now available through our Spatial Omics as a Service program.
Company Overview
Media & News
Funding & FinancialsRebus Biosystems has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Nov 03, 2022 in the amount of $18M.
Rebus Biosystems's revenue is in the range of $10M
Funding & FinancialsRebus Biosystems has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Nov 03, 2022 in the amount of $18M.
Rebus Biosystems's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com